Join
Live feed
·
PRReleasevia Quantisnow
Lipocine Inc. logo

Positive Topline Clinical Results Support Streamlined Development Pathway for LPCN 1154, Lipocine's Oral Candidate for Rapid Relief of Depression

ByQuantisnow·Wall Street's wire, on your screen.
LPCN· Lipocine Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LPCN (Lipocine Inc.) and more on Quantisnow.